NovoCure Ltd - 8-K Filing

Timothy Scannell retired from NovoCure's board effective Sept. 2, 2026; no disagreement with the company (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $NVCR

Read the full article at SEC EDGAR

More Regulatory news